Jaju Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 01-01-2025
- Paid Up Capital ₹ 0.79 M
as on 01-01-2025
- Company Age 22 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.10 M
as on 01-01-2025
- Satisfied Charges ₹ 0.95 M
as on 01-01-2025
- Revenue 7.86%
(FY 2022)
- Profit -2.39%
(FY 2022)
- Ebitda -4.80%
(FY 2022)
- Net Worth 16.62%
(FY 2022)
- Total Assets 46.34%
(FY 2022)
About Jaju Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.79 M.
The company currently has active open charges totaling ₹1.10 M. The company has closed loans amounting to ₹0.95 M, as per Ministry of Corporate Affairs (MCA) records.
Pramod Jaju, Saurabhraj Jaju, Pooja Jaju, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231DL2002PTC117013
- Company No.
117013
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Sep 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jaju Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pramod Jaju  | Director | 17-Sep-2002 | Current |
| Saurabhraj Jaju | Director | 17-Sep-2002 | Current |
| Pooja Jaju | Additional Director | 05-Aug-2024 | Current |
| Saharsh Jaju | Additional Director | 01-Apr-2024 | Current |
Financial Performance of Jaju Pharmaceuticals.
Jaju Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.86% increase. The company also saw a slight decrease in profitability, with a 2.39% decrease in profit. The company's net worth Soared by an impressive increase of 16.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jaju Pharmaceuticals?
In 2022, Jaju Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shri Govind Kripa Builders And Promoters Private LimitedActive 27 years 1 monthPramod Jaju and Saurabhraj Jaju are mutual person
- Purnaakriti Constructions Private LimitedActive 18 years 11 months
Saurabhraj Jaju is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 29 Mar 2010 | ₹0.60 M | Open |
Punjab National Bank Creation Date: 29 Mar 2010 | ₹0.50 M | Open |
Punjab National Bank Creation Date: 17 Nov 2003 | ₹0.95 M | Satisfied |
How Many Employees Work at Jaju Pharmaceuticals?
Unlock and access historical data on people associated with Jaju Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jaju Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jaju Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
